4.6 Article

Clinical and neuroanatomical predictors of cerebellar mutism syndrome

期刊

NEURO-ONCOLOGY
卷 14, 期 10, 页码 1294-1303

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nos160

关键词

cerebellar mutism syndrome; cerebello-thalamo-cerebral pathway; diffusion tensor imaging; posterior fossa syndrome; posterior fossa tumors

资金

  1. Pediatric Oncology Group of Ontario
  2. C17 Research Network
  3. Canadian Cancer Society [18062]

向作者/读者索取更多资源

Cerebellar mutism syndrome (CMS) is an important medical challenge in the management of pediatric posterior fossa brain tumors, because it occurs in a subset of children following tumor resection. A definitive clinical profile and neuroanatomical substrate associated with CMS remains unclear. We investigated the relationship between presurgical and clinical variables and the incidence of CMS, along with diffusion tensor imaging, to characterize the integrity of cerebello-thalamo-cerebral white matter pathways. Seventeen children with posterior fossa tumors and CMS, 34 children with posterior fossa tumors without CMS, and 28 healthy children were enrolled in this study. Bilateral cerebello-thalamo-cerebral pathways were delineated and segmented into anatomical regions. Mean integrity measures for each region were compared among children with CMS, children without CMS, and healthy children. Left-handedness, medulloblastoma histology, and larger tumor size distinguished between patients with CMS and patients without CMS (P .04). Right cerebellar white matter within the cerebello-thalamo-cerebral pathway was compromised in children with CMS relative to children without CMS and healthy children (P .02). We provide a potential schema for CMS risk among children treated for posterior fossa tumors. Left-handed children treated for medulloblastoma may be the most at risk for CMS, and unilateral, localized damage within the cerebello-thalamo-cerebral pathway at the level of the right cerebellum is implicated in the presentation of CMS. This disruption in communication between the right cerebellum and left frontal cortex may contribute to speech-language problems observed in children with CMS. Our findings may be relevant for surgical planning and speech-language therapy to mitigate symptoms of CMS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature

George Michaiel, Douglas Strother, Nicholas Gottardo, Ute Bartels, Hallie Coltin, Juliette Hukin, Beverly Wilson, Shayna Zelcer, Jordan R. Hansford, Timothy Hassall, Mohamed S. AbdelBaki, Kristina A. Cole, Lindsey Hoffman, Natasha P. Smiley, Amy Smith, Anna Vinitsky, Nicholas A. Vitanza, Avery Wright, Kee K. Yeo, Lionel M. L. Chow, Magimairajan Vanan, Girish Dhall, Eric Bouffet, Lucie Lafay-Cousin

JOURNAL OF NEURO-ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma

Laura K. Donovan, Alberto Delaidelli, Sujith K. Joseph, Kevin Bielamowicz, Kristen Fousek, Borja L. Holgado, Alex Manno, Dilakshan Srikanthan, Ahmed Z. Gad, Randy Van Ommeren, David Przelicki, Cory Richman, Vijay Ramaswamy, Craig Daniels, Jonelle G. Pallota, Tajana Douglas, Alyssa C. M. Joynt, Joonas Haapasalo, Carolina Nor, Maria C. Vladoiu, Claudia M. Kuzan-Fischer, Livia Garzia, Stephen C. Mack, Srinidhi Varadharajan, Matthew L. Baker, Liam Hendrikse, Michelle Ly, Kaitlin Kharas, Polina Balin, Xiaochong Wu, Lei Qin, Ning Huang, Ana Guerreiro Stucklin, A. Sorana Morrissy, Florence M. G. Cavalli, Betty Luu, Raul Suarez, Pasqualino De Antonellis, Antony Michealraj, Avesta Rastan, Meenakshi Hegde, Martin Komosa, Olga Sirbu, Sachin A. Kumar, Zied Abdullaev, Claudia C. Faria, Stephen Yip, Juliette Hukin, Uri Tabori, Cynthia Hawkins, Ken Aldape, Mads Daugaard, John M. Maris, Poul H. Sorensen, Nabil Ahmed, Michael D. Taylor

NATURE MEDICINE (2020)

Article Oncology

Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on Head Start III: a multi-institutional, prospective clinical trial

Girish Dhall, Sharon H. O'Neil, Lingyun Ji, Kelley Haley, Ashley M. Whitaker, Marvin D. Nelson, Floyd Gilles, Sharon L. Gardner, Jeffrey C. Allen, Albert S. Cornelius, Kamnesh Pradhan, James H. Garvin, Randal S. Olshefski, Juliette Hukin, Melanie Comito, Stewart Goldman, Mark P. Atlas, Andrew W. Walter, Stephen Sands, Richard Sposto, Jonathan L. Finlay

NEURO-ONCOLOGY (2020)

Article Pathology

Pontine Embryonal Tumor With Multilayered Rosettes: An Autopsy Case Exhibiting Extensive Posttreatment Glial and Neuronal Maturation

Adrian Levine, Juliette Hukin, Christopher Dunham

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)

Article Oncology

Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC)

Adriana Fonseca, Samina Afzal, Lynette Bowes, Bruce Crooks, Valerie Larouche, Nada Jabado, Sebastien Perreault, Donna L. Johnston, Shayna Zelcer, Adam Fleming, Katrin Scheinemann, Mariana Silva, Magimairajan Issai Vanan, Chris Mpofu, Beverly Wilson, David D. Eisenstat, Lucie Lafay-Cousin, Juliette Hukin, Cynthia Hawkins, Ute Bartels, Eric Bouffet

JOURNAL OF NEURO-ONCOLOGY (2020)

Editorial Material Clinical Neurology

Factors influencing cognitive outcome in opsoclonus-myoclonus syndrome

Juliette Hukin

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2020)

Article Oncology

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

Rahul Kumar, Kyle S. Smith, Maximilian Deng, Colt Terhune, Giles W. Robinson, Brent A. Orr, Anthony P. Y. Liu, Tong Lin, Catherine A. Billups, Murali Chintagumpala, Daniel C. Bowers, Timothy E. Hassall, Jordan R. Hansford, Dong Anh Khuong-Quang, John R. Crawford, Anne E. Bendel, Sridharan Gururangan, Kristin Schroeder, Eric Bouffet, Ute Bartels, Michael J. Fisher, Richard Cohn, Sonia Partap, Stewart J. Kellie, Geoffrey McCowage, Arnold C. Paulino, Stefan Rutkowski, Gudrun Fleischhack, Girish Dhall, Laura J. Klesse, Sarah Leary, Javad Nazarian, Marcel Kool, Pieter Wesseling, Marina Ryzhova, Olga Zheludkova, Andrey Golanov, Roger E. McLendon, Roger J. Packer, Christopher Dunham, Juliette Hukin, Maryam Fouladi, Claudia C. Faria, Jose Pimentel, Andrew W. Walter, Nada Jabado, Yoon-Jae Cho, Sebastien Perreault, Sidney E. Croul, Michal Zapotocky, Cynthia Hawkins, Uri Tabori, Michael D. Taylor, Stefan M. Pfister, Paul Klimo, Frederick A. Boop, David W. Ellison, Thomas E. Merchant, Arzu Onar-Thomas, Andrey Korshunov, David T. W. Jones, Amar Gajjar, Vijay Ramaswamy, Paul A. Northcott

Summary: The study investigated clinical outcomes of relapsed medulloblastoma and compared molecular features between patient-matched diagnostic and relapsed tumors. Results showed variations in molecular subgroup performance and survival status at relapse.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Pathology

Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review

Joanna Triscott, Stephen Yip, Donna Johnston, Jean Michaud, Shahrad R. Rassekh, Juliette Hukin, Sandra Dunn, Christopher Dunham

Summary: The study reviewed 120 cases of pediatric medulloblastoma and found that nodularity without desmoplasia and rhythmic palisades were more common in non-WNT/SHH molecular groups, while focal anaplasia was predictive of unfavorable outcomes.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2021)

Article Oncology

Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma

Rebecca Ronsley, Celine D. Hounjet, Sylvia Cheng, Shahrad Rod Rassekh, Walter J. Duncan, Christopher Dunham, Jane Gardiner, Arvindera Ghag, Jeffrey P. Ludemann, David Wensley, Wingfield Rehmus, Michael A. Sargent, Juliette Hukin

Summary: Six NF-1 patients were treated with trametinib, showing either partial response or stability in all cases, with generally well-tolerated adverse effects of grade 1-2 paronychia or dermatitis. Further data and clinical trials are needed to assess the efficacy and durability of this treatment method.

CANCER MEDICINE (2021)

Correction Biochemistry & Molecular Biology

Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma (vol 26, pg 720, 2020)

Laura K. Donovan, Alberto Delaidelli, Sujith K. Joseph, Kevin Bielamowicz, Kristen Fousek, Borja L. Holgado, Alex Manno, Dilakshan Srikanthan, Ahmed Z. Gad, Randy Van Ommeren, David Przelicki, Cory Richman, Vijay Ramaswamy, Craig Daniels, Jonelle G. Pallota, Tajana Douglas, Alyssa C. M. Joynt, Joonas Haapasalo, Carolina Nor, Maria C. Vladoiu, Claudia M. Kuzan-Fischer, Livia Garzia, Stephen C. Mack, Srinidhi Varadharajan, Matthew L. Baker, Liam Hendrikse, Michelle Ly, Kaitlin Kharas, Polina Balin, Xiaochong Wu, Lei Qin, Ning Huang, Ana Guerreiro Stucklin, A. Sorana Morrissy, Florence M. G. Cavalli, Betty Luu, Raul Suarez, Pasqualino De Antonellis, Antony Michealraj, Avesta Rastan, Meenakshi Hegde, Martin Komosa, Olga Sirbu, Sachin A. Kumar, Zied Abdullaev, Claudia C. Faria, Stephen Yip, Juliette Hukin, Uri Tabori, Cynthia Hawkins, Ken Aldape, Mads Daugaard, John M. Maris, Poul H. Sorensen, Nabil Ahmed, Michael D. Taylor

NATURE MEDICINE (2021)

Article Oncology

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma

Richard T. Graham, Mohammad H. Abu-Arja, Joseph R. Stanek, Andrea Cappellano, Christina Coleman, Susan Chi, Tabitha Cooney, Girish Dhall, Jacob G. Ellen, Jonathan L. Finlay, Michael J. Fisher, Gregory K. Friedman, Amar Gajjar, Karen Gauvain, Lindsey M. Hoffman, Juliette Hukin, John T. Lucas, Sabine Mueller, Pournima Navalkele, Rebecca Ronsley, Christopher Tinkle, Stephanie Villeneuve, Kee Kiat Yeo, Jack M. Su, Ashley Margol, Nicholas G. Gottardo, Jeffrey Allen, Roger Packer, Ute Bartels, Mohamed S. Abdelbaki

Summary: Patients with basal ganglia/thalamus germinomas have excellent survival outcomes, with combined chemotherapy and radiotherapy showing superior efficacy compared to chemotherapy alone. Radiotherapy is proven to be an integral component in the treatment plan for these patients.

PEDIATRIC BLOOD & CANCER (2021)

Review Clinical Neurology

Treatment-responsive Holmes tremor in a child with low-pressure hydrocephalus: video case report and systematic review of the literature

Stephano J. Chang, Ruth Mitchell, Juliette Hukin, Ash Singhal

Summary: Holmes tremor (HT) is a rare and difficult-to-treat movement disorder associated with hydrocephalus. Treatment options include CSF diversion, antiparkinsonian agents, antiepileptic agents, deep brain stimulation, and MR-guided focused ultrasound.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2022)

Article Clinical Neurology

Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC

Martin Hasselblatt, Christian Thomas, Aniello Federico, Susanne Bens, Mats Hellstrom, Olivera Casar-Borota, Uwe Kordes, Julia E. Neumann, Matthias Dottermusch, Fausto J. Rodriguez, Andrea C. Lo, Sylvia Cheng, Glenda Hendson, Juliette Hukin, Christian Hartmann, Arend Koch, David Capper, Reiner Siebert, Werner Paulus, Karolina Nemes, Pascal D. Johann, Michael C. Fruehwald, Marcel Kool

Summary: Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant, is a distinctive low-grade lesion found in older children and young adults, showing epigenetic similarity with ATRT-MYC and having the potential for malignant progression.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Article Cell Biology

Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

Pooja Panwalkar, Benita Tamrazi, Derek Dang, Chan Chung, Stefan Sweha, Siva Kumar Natarajan, Matthew Pun, Jill Bayliss, Martin P. Ogrodzinski, Drew Pratt, Brendan Mullan, Debra Hawes, Fusheng Yang, Chao Lu, Benjamin R. Sabari, Abhinav Achreja, Jin Heon, Olamide Animasahun, Marcin Cieslik, Christopher Dunham, Stephen Yip, Juliette Hukin, Joanna J. Phillips, Miriam Bornhorst, Andrea M. Griesinger, Andrew M. Donson, Nicholas K. Foreman, Hugh J. L. Garton, Jason Heth, Karin Muraszko, Javad Nazarian, Carl Koschmann, Li Jiang, Mariella G. Filbin, Deepak Nagrath, Marcel Kool, Andrey Korshunov, Stefan M. Pfister, Richard J. Gilbertson, C. David Allis, Arul M. Chinnaiyan, Sophia Y. Lunt, Stefan Bluml, Alexander R. Judkins, Sriram Venneti

Summary: Childhood posterior fossa group A ependymomas (PFAs) have limited treatment options and poor prognoses compared to group B ependymomas (PFBs). PFAs exhibit enhanced glycolysis and tricarboxylic acid (TCA) cycle metabolism, with high expression of glycolytic genes associated with a poor outcome. These tumors also show high EZHIP expression linked to a dismal prognosis and elevated activating mark histone H3 lysine 27 acetylation (H3K27ac). Repurposing the antidiabetic drug metformin has shown therapeutic efficacy in vitro and in vivo in patient-derived PFA xenografts by targeting integrated metabolic/epigenetic pathways.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Oncology

Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study

Craig Erker, Martin Mynarek, Simon Bailey, Claire M. Mazewski, Lorena Baroni, Maura Massimino, Juliette Hukin, Dolly Aguilera, Andrea M. Cappellano, Vijay Ramaswamy, Alvaro Lassaletta, Sebastien Perreault, Cassie N. Kline, Revathi Rajagopal, George Michaiel, Michal Zapotocky, Vicente Santa-Maria Lopez, Andres Morales La Madrid, Chantel Cacciotti, Eric S. Sandler, Lindsey M. Hoffman, Darren Klawinski, Sara Khan, Ralph Salloum, Anna L. Hoppmann, Valerie Larouche, Kathleen Dorris, Helen Toledano, Stephen W. Gilheeney, Mohamed S. Abdelbaki, Beverly Wilson, Derek S. Tsang, Jeffrey Knipstein, Michal Yalon Oren, Shafqat Shah, Jeffrey C. Murray, Kevin F. Ginn, Zhihong J. Wang, Gudrun Fleischhack, Denise Obrecht, Svenja Tonn, Virginia L. Harrod, Kara Matheson, Bruce Crooks, Douglas R. Strother, Kenneth J. Cohen, Jordan R. Hansford, Sabine Mueller, Ashley Margol, Amar Gajjar, Girish Dhall, Jonathan L. Finlay, Paul A. Northcott, Stefan Rutkowski, Steven C. Clifford, Giles Robinson, Eric Bouffet, Lucie Lafay-Cousin

Summary: The purpose of this study was to assess salvage strategies and prognostic features of patients with infant and young childhood medulloblastoma (iMB) who relapse after craniospinal irradiation (CSI)-sparing therapy. The results showed that the 3-year postrelapse survival rate for patients treated with curative intent was 52.4%. Salvage radiotherapy and chemotherapy might be beneficial for a subset of patients. Therefore, CSI-sparing therapy can be effective in a substantial proportion of relapsed iMB patients.

JOURNAL OF CLINICAL ONCOLOGY (2023)

暂无数据